The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.
Over 300,000 attend UAE Eid events dedicated to workers
Dubai Customs boost readiness for returning Hajj pilgrims, Eid travellers
Dubai Police honour resident for returning AED 100,000
Sheikh Abdullah condemns Iranian attacks in phone call with Kuwaiti FM
